Zai Lab ZLAB
NASDAQ ZLAB
$24.33 -1.17 (-4.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zai Lab (ZLAB) Return on Sales [ROS] (2019 - 2026)

Updated

Zai Lab (ZLAB) posted Return on Sales [ROS] of -71.95% for Q2 2026, down 22.03 percentage points from -49.91% a year earlier and down 2.29 percentage points from the prior quarter.

Analysis

Zai Lab (ZLAB) Return on Sales [ROS] (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Zai Lab was -58.74%, down 1.01 percentage points year-over-year; for FY2025, it was -49.86%, up 20.85 percentage points from FY2024.

  • Annual Return on Sales [ROS] has increased for seven consecutive years, with a five-year change of +566.59 percentage points (FY2020 to FY2025).
  • In prior years, Zai Lab's Return on Sales [ROS] was -70.71% in FY2024 (+66.73 pp), -137.44% in FY2023 (+50.60 pp), -188.04% in FY2022 (+297.07 pp) and -485.10% in FY2021 (+131.34 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Sales [ROS] since Q2 2024.
  • On a year-over-year basis, Return on Sales [ROS] increased in six of the last eight quarters, with an average year-over-year change of +28.42 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2022, with a gain of 958.93 percentage points; the weakest was Q4 2023, with a drop of 32.92 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -69.66% (Q1 2026), -54.39% (Q4 2025) and -42.05% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Zai Lab 2.73 Bn 45.34 Mn 58.15 Mn -71.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -71.95%
Mar 31, 2026 -69.66%
Dec 31, 2025 -54.39%
Sep 30, 2025 -42.05%
Jun 30, 2025 -49.91%
Mar 31, 2025 -52.88%
Dec 31, 2024 -62.25%
Sep 30, 2024 -66.35%
Jun 30, 2024 -75.68%
Mar 31, 2024 -80.68%
Dec 31, 2023 -188.34%
Sep 30, 2023 -120.72%
Jun 30, 2023 -129.97%
Mar 31, 2023 -110.71%
Dec 31, 2022 -155.42%
Sep 30, 2022 -223.47%
Jun 30, 2022 -204.91%
Mar 31, 2022 -170.71%
Dec 31, 2021 -498.58%
Sep 30, 2021 -193.04%
API Access

Zai Lab Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ZLAB&period=max&api_key=YOUR_API_KEY